Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2013 (2013), Article ID 258095, 9 pages
http://dx.doi.org/10.1155/2013/258095
Research Article

Harmine and Harmaline Downregulate TCDD-Induced Cyp1a1 in the Livers and Lungs of C57BL/6 Mice

Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB, Canada T6G 2E1

Received 28 July 2012; Revised 24 September 2012; Accepted 24 September 2012

Academic Editor: Leandro Machado Rocha

Copyright © 2013 Mohamed A. M. El Gendy and Ayman O. S. El-Kadi. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Warner, P. Mocarelli, S. Samuels, L. Needham, P. Brambilla, and B. Eskenazi, “Dioxin exposure and cancer risk in the Seveso Women's Health Study,” Environmental Health Perspectives, vol. 119, no. 12, pp. 1700–1705, 2011. View at Google Scholar
  2. M. S. Denison, A. A. Soshilov, G. He, D. E. DeGroot, and B. Zhao, “Exactly the same but different: promiscuity and diversity in the molecular mechanisms of action of the aryl hydrocarbon (dioxin) receptor,” Toxicological Sciences, vol. 124, no. 1, pp. 1–22, 2011. View at Google Scholar
  3. T. Shimada, A. Sugie, T. Yamada et al., “Dose-response studies on the induction of liver cytochromes P4501A1 and 1B1 by polycyclic aromatic hydrocarbons in arylhydrocarbon-responsive C57BL/6J mice,” Xenobiotica, vol. 33, no. 9, pp. 957–971, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. T. Oyama, K. Sugio, H. Uramoto et al., “Cytochrome P450 expression (CYP) in non-small cell lung cancer,” Frontiers in Bioscience, vol. 12, no. 6, pp. 2299–2308, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. M. L. Slattery, W. Samowtiz, K. Ma et al., “CYP1A1, cigarette smoking, and colon and rectal cancer,” American Journal of Epidemiology, vol. 160, no. 9, pp. 842–852, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. D. Puppala, H. Lee, B. K. Kyung, and H. I. Swanson, “Development of an aryl hydrocarbon receptor antagonist using the proteolysis-targeting chimeric molecules approach: a potential tool for chemoprevention,” Molecular Pharmacology, vol. 73, no. 4, pp. 1064–1071, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Cao, W. Peng, Z. Wang, and A. Xu, “β-carboline alkaloids: biochemical and pharmacological functions,” Current Medicinal Chemistry, vol. 14, no. 4, pp. 479–500, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. M. A. M. El Gendy, V. Somayaji, and A. O. S. El-Kadi, “Peganum harmala L. is a candidate herbal plant for preventing dioxin mediated effects,” Planta Medica, vol. 76, no. 7, pp. 671–677, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. M. A. M. El Gendy, A. A. Soshilov, M. S. Denison, and A. O. El-Kadi, “Harmaline and harmalol inhibit the carcinogen-activating enzyme CYP1A1 via transcriptional and posttranslational mechanisms,” Food and Chemical Toxicology, vol. 50, no. 2, pp. 353–362, 2012. View at Google Scholar
  10. M. A. M. El Gendy, A. A. Soshilov, M. S. Denison, and A. O. El-Kadi, “Transcriptional and posttranslational inhibition of dioxin-mediated induction of CYP1A1 by harmine and harmol,” Toxicology Letters, vol. 208, no. 1, pp. 51–61, 2012. View at Google Scholar
  11. B. N. M. Zordoky, M. E. Aboutabl, and A. O. S. El-Kadi, “Modulation of cytochrome P450 gene expression and arachidonic acid metabolism during isoproterenol-induced cardiac hypertrophy in rats,” Drug Metabolism and Disposition, vol. 36, no. 11, pp. 2277–2286, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. M. A. M. El Gendy and A. O. S. El-Kadi, “Peganum harmala L. differentially modulates cytochrome P450 gene expression in human hepatoma HepG2 cells,” Drug Metabolism Letters, vol. 3, no. 4, pp. 212–216, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. T. D. Schmittgen and B. A. Zakrajsek, “Effect of experimental treatment on housekeeping gene expression: validation by real-time, quantitative RT-PCR,” Journal of Biochemical and Biophysical Methods, vol. 46, no. 1-2, pp. 69–81, 2000. View at Publisher · View at Google Scholar · View at Scopus
  14. K. J. Livak and T. D. Schmittgen, “Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method,” Methods, vol. 25, no. 4, pp. 402–408, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. M. M. Barakat, A. O. S. El-Kadi, and P. du Souich, “L-NAME prevents in vivo the inactivation but not the down-regulation of hepatic cytochrome P450 caused by an acute inflammatory reaction,” Life Sciences, vol. 69, no. 13, pp. 1559–1571, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. O. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall, “Protein measurement with the Folin phenol reagent,” Journal of Biological Chemistry, vol. 193, no. 1, pp. 265–275, 1951. View at Google Scholar · View at Scopus
  17. S. Safe, S. Papineni, and S. Chintharlapalli, “Cancer chemotherapy with indole-3-carbinol, bis(3′-indolyl)methane and synthetic analogs,” Cancer Letters, vol. 269, no. 2, pp. 326–338, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. T. V. Beischlag, J. L. Morales, B. D. Hollingshead, and G. H. Perdew, “The aryl hydrocarbon receptor complex and the control of gene expression,” Critical Reviews in Eukaryotic Gene Expression, vol. 18, no. 3, pp. 207–250, 2008. View at Google Scholar · View at Scopus
  19. F. J. Gonzalez and P. Fernandez-Salguero, “The aryl hydrocarbon receptor. Studies using the AHR-null mice,” Drug Metabolism and Disposition, vol. 26, no. 12, pp. 1194–l198, 1998. View at Google Scholar · View at Scopus
  20. T. Shimada and Y. Fujii-Kuriyama, “Metabolic activation of polycyclic aromatic hydrocarbons to carcinogens by cytochromes P450 1A1 and 1B1,” Cancer Science, vol. 95, no. 1, pp. 1–6, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Y. K. Park, M. K. Shigenaga, and B. N. Ames, “Induction of cytochrome P4501A1 by 2,3,7,8-tetrachlorodibenzo-p-dioxin or indolo(3,2-b)carbazole is associated with oxidative DNA damage,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 6, pp. 2322–2327, 1996. View at Publisher · View at Google Scholar · View at Scopus
  22. S. D. Dertinger, D. A. Nazarenko, A. E. Silverstone, and T. A. Gasiewicz, “Aryl hydrocarbon receptor signaling plays a significant role in mediating benzo[a]pyrene- and cigarette smoke condensate-induced cytogenetic damage in vivo,” Carcinogenesis, vol. 22, no. 1, pp. 171–177, 2001. View at Google Scholar · View at Scopus
  23. A. Revel, H. Raanani, E. Younglai et al., “Resveratrol, a natural aryl hydrocarbon receptor antagonist, protects lung from DNA damage and apoptosis caused by benzo[a]pyrene,” Journal of Applied Toxicology, vol. 23, no. 4, pp. 255–261, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. A. M. Yu, J. R. Idle, K. W. Krausz, A. Küpfer, and F. J. Gonzalez, “Contribution of individual cytochrome P450 isozymes to the O-demethylation of the psychotropic β-carboline alkaloids harmaline and harmine,” Journal of Pharmacology and Experimental Therapeutics, vol. 305, no. 1, pp. 315–322, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. R. P. Koshakji, R. D. Harbison, and M. T. Bush, “Studies on the metabolic fate of [14C]2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the mouse,” Toxicology and Applied Pharmacology, vol. 73, no. 1, pp. 69–77, 1984. View at Google Scholar · View at Scopus
  26. D. A. Nazarenko, S. D. Dertinger, and T. A. Gasiewicz, “In vivo antagonism of AhR-mediated gene induction by 3′-methoxy-4′-nitroflavone in TCDD-responsive lacZ mice,” Toxicological Sciences, vol. 61, no. 2, pp. 256–264, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. G. Zetler, G. Back, and H. Iven, “Pharmacokinetics in the rat of the hallucinogenic alkaloids harmine and harmaline,” Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 285, no. 3, pp. 273–292, 1974. View at Publisher · View at Google Scholar · View at Scopus
  28. K. Hu and N. J. Bunce, “Metabolism of polychlorinated dibenzo-p-dioxins and related dioxin-like compounds,” Journal of Toxicology and Environmental Health B, vol. 2, no. 2, pp. 183–210, 1999. View at Google Scholar · View at Scopus
  29. J. J. Diliberto, D. Burgin, and L. S. Birnbaum, “Role of CYP1A2 in hepatic sequestration of dioxin: studies using CYP1A2 knock-out mice,” Biochemical and Biophysical Research Communications, vol. 236, no. 2, pp. 431–433, 1997. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Nukaya, J. A. Walisser, S. M. Moran, G. D. Kennedy, and C. A. Bradfield, “Aryl hydrocarbon receptor nuclear translocator in hepatocytes is required for aryl hydrocarbon receptor-mediated adaptive and toxic responses in liver,” Toxicological Sciences, vol. 118, no. 2, pp. 554–563, 2010. View at Publisher · View at Google Scholar · View at Scopus